Baidu
map

JAMA Psychiatry:可卡因成瘾机制研究

2015-04-30 赵洲译 MedSci原创

药物成瘾是一种慢性的、复发的脑部疾病,其主要特征就是强迫性寻找和服用药物。作为一个与药物成瘾相关的特征,当服用可卡因时,冲动是一个风险因素且变得更为糟糕。与此相反,强迫性药物使用是这一疾病的主要特征。在可卡因使用者中,冲动和强迫都和不正常的额叶皮质纹状体区结构。大量证据已经证明冲动和强迫在药物成瘾的生理过程中起到了关键性的作用。但脑部网络和成瘾性的关系尚不明确。 为了检验可卡因与纹状体-皮质

药物成瘾是一种慢性的、复发的脑部疾病,其主要特征就是强迫性寻找和服用药物。作为一个与药物成瘾相关的特征,当服用可卡因时,冲动是一个风险因素且变得更为糟糕。与此相反,强迫性药物使用是这一疾病的主要特征。在可卡因使用者中,冲动和强迫都和不正常的额叶皮质纹状体区结构。大量证据已经证明冲动和强迫在药物成瘾的生理过程中起到了关键性的作用。但脑部网络和成瘾性的关系尚不明确。

为了检验可卡因与纹状体-皮质通讯干扰有关的假设,研究人员进行了一次案例对照的代表性研究。试验数据在2005年到2011年之间采集的。受试者包括56名可卡因使用者(52人是可卡因依赖、3人是可卡因滥用),另有56人作为对照组(性别、年龄、教育时间、种族、智商和吸烟状态相符)。主要监测指标是两组之间静息状态功能连接强度(rsFC)的差异。在纹状体-皮质循环中,增强的rsFC强度很显著。

研究结果表明,可卡因成瘾和几种具体的纹状体-皮质循环中的受到干扰的rsFC有关。对大脑各个区域的研究为药物成瘾的神经生物学机制提供了新的视角。也为药物成瘾的治疗提供了潜在的新型治疗靶点。这对治疗药物成瘾将有重大的意义。
 
原始出处:

Hu Y, Salmeron B, Gu H, Stein EA, Yang Y. Impaired Functional Connectivity Within and Between Frontostriatal Circuits and Its Association With Compulsive Drug Use and Trait Impulsivity in Cocaine Addiction. JAMA Psychiatry. Published online April 08, 2015. doi:10.1001/jamapsychiatry.2015.1.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2056127, encodeId=63d9205612ecd, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 22 03:16:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791913, encodeId=cd3f1e91913bf, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jun 25 18:16:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481680, encodeId=359c1481680e5, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Sat May 02 04:16:00 CST 2015, time=2015-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493788, encodeId=f1131493e886a, content=<a href='/topic/show?id=be6e3842e92' target=_blank style='color:#2F92EE;'>#可卡因成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38427, encryptionId=be6e3842e92, topicName=可卡因成瘾)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=360d9095294, createdName=xlysu, createdTime=Sat May 02 04:16:00 CST 2015, time=2015-05-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2056127, encodeId=63d9205612ecd, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 22 03:16:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791913, encodeId=cd3f1e91913bf, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jun 25 18:16:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481680, encodeId=359c1481680e5, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Sat May 02 04:16:00 CST 2015, time=2015-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493788, encodeId=f1131493e886a, content=<a href='/topic/show?id=be6e3842e92' target=_blank style='color:#2F92EE;'>#可卡因成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38427, encryptionId=be6e3842e92, topicName=可卡因成瘾)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=360d9095294, createdName=xlysu, createdTime=Sat May 02 04:16:00 CST 2015, time=2015-05-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2056127, encodeId=63d9205612ecd, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 22 03:16:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791913, encodeId=cd3f1e91913bf, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jun 25 18:16:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481680, encodeId=359c1481680e5, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Sat May 02 04:16:00 CST 2015, time=2015-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493788, encodeId=f1131493e886a, content=<a href='/topic/show?id=be6e3842e92' target=_blank style='color:#2F92EE;'>#可卡因成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38427, encryptionId=be6e3842e92, topicName=可卡因成瘾)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=360d9095294, createdName=xlysu, createdTime=Sat May 02 04:16:00 CST 2015, time=2015-05-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2056127, encodeId=63d9205612ecd, content=<a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61179, encryptionId=616b611e9bc, topicName=机制研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Aug 22 03:16:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791913, encodeId=cd3f1e91913bf, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jun 25 18:16:00 CST 2015, time=2015-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481680, encodeId=359c1481680e5, content=<a href='/topic/show?id=7099384244c' target=_blank style='color:#2F92EE;'>#可卡因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38424, encryptionId=7099384244c, topicName=可卡因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbbf7815801, createdName=12498b3em10(暂无昵称), createdTime=Sat May 02 04:16:00 CST 2015, time=2015-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493788, encodeId=f1131493e886a, content=<a href='/topic/show?id=be6e3842e92' target=_blank style='color:#2F92EE;'>#可卡因成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38427, encryptionId=be6e3842e92, topicName=可卡因成瘾)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=360d9095294, createdName=xlysu, createdTime=Sat May 02 04:16:00 CST 2015, time=2015-05-02, status=1, ipAttribution=)]

相关资讯

Nat Neurosci:研究发现可卡因可快速改变大脑构造

日前,美国研究人员表示,服用可卡因能够在数小时内改变大脑的构造,成为吸毒上瘾的第一步。《自然神经科学》(Nature Neuroscience)期刊发表的报告说,实验显示,让动物服用可卡因后不久,与学习和记忆有关的新结构开始生长。实验表明,大脑发生变化最多的小白鼠显示出对可卡因的更多偏好。专家把这种情况形容为大脑“学习上瘾”。美国加州大学伯克莱分校和旧金山分校的研究小组寻找名为树状突棘的大脑微小细

Nature:由可卡因诱导的脑变化导致毒瘾复发

上瘾药物被认为会劫持向各种不同的脑区域发送信号以控制行为反应的一体化脑中心(如伏核)中的神经回路。由于这样的操纵,与药物相关的提示信息会成为寻找药物行为的强大诱因,在停止用药(吸毒)后增加复发的机会。 在这项研究中,Christian Lüscher 及同事在来自前额皮质或背侧海马体的投射中,识别出了与小鼠伏核中的不同多巴胺能类群发生相互作用的特定神经通道所发生的由可卡因激发的改变。对这

可卡因与可口可乐——双面古柯叶

作为世界主要毒品之一,可卡因受到禁毒人士的深恶痛绝;作为风靡全球的汽水,可口可乐受到各国人民的喜爱。这两个截然不同的产品,却有着千丝万缕的联系。把它们联系在一起的,就是本文的主角——古柯叶。古柯叶的前世今生:从药物到毒品一说可卡因,总会让人联想到毒品,大家免不了要大谈特谈一番。不过可卡因只是本文的配角啦。先来说说本文的主角,可卡因他娘——古柯叶。看看官方介绍:古柯,南美安地斯山脉斜坡上的一类灌木,

Circulation:心肌声学造影技术发现可卡因收缩冠脉微血管新证据

基础水平以及低剂量可卡因心肌声学影像学表现 图注:上图为,不同时间间隔左心室心肌声学显像二维图像。表A,基础水平以及摄入多巴酚丁胺条件下心肌收缩时间-强度曲线表B,基础水平以及摄入多巴酚丁胺条件下心肌灌注对比表C,基础水平以及摄入多巴酚丁胺条件下心肌灌注/MVO2 可卡因是目前世界上第二大滥用药物,长期使用可卡因可增加心血管事件风险,它也是年轻人发生急性冠脉综合征的主要因素之一。尽管可卡因

PNAS:揭示可卡因的使用和社会性愉悦

一项研究发现,可卡因使用者表现出了在社会互动期间迟钝的情绪响应和大脑的奖赏中心的较低的激活状态。滥用毒品与缺乏移情作用等社会削弱有关联。Katrin Preller及其同事研究了这些长期缺陷是否可能通过社会互动期间缺乏愉悦加以解释。在这项研究中,80名可卡因使用者和63名健康的对照者与一个显示在计算机屏幕上的虚拟人物互动。在联合注意测试中,这些受试者和虚拟人物通过注视屏幕上的同一个物体从而共享一种

J Neurosci:可卡因影响记忆力的分子机理

近日,一项刊登于国际杂志Journal of Neuroscience上的研究论文中,来自华盛顿州立大学的研究人员通过研究发现了大脑中的一种新型机制,其在个体大脑药物成瘾记忆中扮演着重要的角色,该研究发现或为开发新型靶向疗法来改变或消除这种机制从而使得降低个体对药物成瘾的强迫性提供了一定的帮助和希望。研究者Barbara Sorg表示,关闭这种机制或许可以逐步减少个体情感上的影响或情绪记忆的内容,

Baidu
map
Baidu
map
Baidu
map